Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

Shots - Health News
6:13 pm
Wed October 31, 2012

Before Sandy Hit U.S., Storm Was A Killer In Haiti

Hurricane Sandy's tear across the Caribbean left at least 54 dead in Haiti, where many people still live in tents because of damage from the 2010 earthquake.
Thony Belizaire AFP/Getty Images

Hurricane Sandy only sideswiped Haiti during its early days. But reports so far suggest that even this indirect hit led to nearly as many deaths there as in the U.S. after the storm made landfall on the Mid-Atlantic coast.

As of Wednesday, Haiti had documented 54 deaths caused by Sandy — most in the nation's southern peninsula, which points toward Jamaica. Another 21 Haitians were still counted as missing, and many fear the death toll will rise as officials reach affected areas isolated by impassable roads and ruined bridges.

Read more
Shots - Health News
5:12 pm
Fri October 26, 2012

FDA Says Massachusetts Pharmacy Knew Of Sterility Problems For Months

A Framingham police officer keeps watch as federal agents search the New England Compounding Center company in Framingham, Mass., on October 16.
Dominick Reuter Reuters /Landov

Originally published on Fri October 26, 2012 5:40 pm

In a highly unusual step, the Food and Drug Administration has released a report of inspections it conduct this month of the Massachusetts pharmacy at the center of a national outbreak of fungal infections.

Read more
Shots - Health News
4:58 am
Wed October 24, 2012

Meningitis From Tainted Drugs Puts Patients, Doctors In Quandary

Matthew Spencer receives intravenous infusions of a potent antifungal drug at home twice a day for an indefinite period to treat a suspected case of fungal infection linked to a contaminated steroid drug that came from New England Compounding Center in Massachusetts.
Richard Knox NPR

Originally published on Wed October 24, 2012 10:58 am

Two weeks after Matthew Spencer got a spinal injection for his chronic back pain, he felt "not quite right." Nothing too specific: worsening headache, nausea.

Then he saw a TV report on a recall of contaminated steroid medication used for back pain.

"I thought, well, I don't know if I had that medicine or not, but maybe I'd better go check it out," Spencer says.

Read more
Shots - Health News
7:03 am
Sat October 20, 2012

CDC: Meningitis Mold In Tainted Drug Can Incubate For Months

Federal agents investigate the offices of the New England Compounding Center in Framingham, Mass., on Tuesday. The company's steroid medication has been linked to a deadly meningitis outbreak.
Barry Chin AP

Originally published on Mon October 22, 2012 12:38 pm

As the caseload of fungal meningitis linked to a tainted steroid drug climbs, experts are learning more about this human-made epidemic. The signs indicate that cases could still be emerging until Thanksgiving or beyond.

The latest count is 268 cases of meningitis and three patients with fungal joint infections, spread across 16 states from New Hampshire to Texas and Idaho to Florida. Twenty-one people have died.

Read more
Shots - Health News
12:29 pm
Thu October 18, 2012

Old Drug Gets A Second Look For TB Fight

Under the microscope, Mycobacterium tuberculosis bacteria. The germs that cause TB have become resistant to many drugs.
Janice Haney Carr CDC

Originally published on Thu October 18, 2012 1:04 pm

A small study offers a bit of cautious optimism about the prospects for treatment of tuberculosis, one of humankind's most ancient scourges.

This week's New England Journal of Medicine has a report showing that adding a 12-year-old antibiotic called linezolid, brand name Zyvox, to existing treatments cured nearly 90 percent of patients with a form of tuberculosis resistant to both first- and second-line antibiotics.

Read more

Pages